Clinical Performance of the Gedea Pessary in Adult Women With Vulvovaginal Candidiasis (EpHect)
An Open Labelled Study to Evaluate Clinical Performance of the Gedea Pessary in Adult Women With Vulvovaginal Candidiasis
Sponsor: Gedea Biotech AB
Listed as NCT05507333, this NA trial focuses on Vulvovaginal Candidiasis and remains completed. Sponsored by Gedea Biotech AB, it has been updated 9 times since 2023, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
9 versions recorded-
Nov 2025 — Present [monthly]
Completed NA
-
Sep 2025 — Nov 2025 [monthly]
Completed NA
-
Sep 2024 — Sep 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Apr 2024 — Jul 2024 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
▶ Show 4 earlier versions
-
Mar 2024 — Apr 2024 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Oct 2023 — Mar 2024 [monthly]
Recruiting NA
-
May 2023 — Oct 2023 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Sep 2022 — May 2023 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Gedea Biotech AB
For direct contact, visit the study record on ClinicalTrials.gov .